$377 Million is the total value of Opaleye Management Inc.'s 44 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 55.6% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
FTSV | Sell | FORTY SEVEN INC | $36,784,000 | +66.2% | 385,500 | -31.4% | 9.75% | +124.6% |
Sell | APTOSE BIOSCIENCES INC | $23,891,000 | +3.1% | 4,022,000 | -1.5% | 6.33% | +39.3% | |
STXS | Sell | STEREOTAXIS INC | $11,662,000 | -47.1% | 3,861,500 | -6.1% | 3.09% | -28.5% |
DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $9,140,000 | -34.6% | 222,000 | -1.1% | 2.42% | -11.7% |
TGTX | Sell | TG THERAPEUTICS INC | $4,851,000 | -24.6% | 493,000 | -14.9% | 1.28% | +1.8% |
ZYME | Sell | ZYMEWORKS INC | $4,718,000 | -40.7% | 133,000 | -24.0% | 1.25% | -19.9% |
MGTA | Sell | MAGENTA THERAPEUTICS INC | $2,730,000 | -59.4% | 434,712 | -3.4% | 0.72% | -45.2% |
FLXN | Sell | FLEXION THERAPEUTICS INC | $2,216,000 | -74.2% | 281,600 | -32.2% | 0.59% | -65.2% |
RDUS | Sell | RADIUS HEALTH INC | $2,171,000 | -35.9% | 167,000 | -0.6% | 0.58% | -13.5% |
AMRN | Sell | AMARIN CORP PLCsponsored adr | $1,820,000 | -87.2% | 455,000 | -31.6% | 0.48% | -82.8% |
TELA | Sell | TELA BIO INC | $633,000 | -72.1% | 81,000 | -53.7% | 0.17% | -62.2% |
ACAD | Sell | ACADIA PHARMACEUTICALS INC | $63,000 | -99.3% | 1,500 | -99.3% | 0.02% | -99.0% |
FENC | Exit | FENNEC PHARMACEUTICALS INC | $0 | – | -12,000 | -100.0% | -0.02% | – |
PRTO | Exit | PROTEON THERAPEUTICS INC | $0 | – | -188,144 | -100.0% | -0.02% | – |
RYTM | Exit | RHYTHM PHARMACEUTICALS INC | $0 | – | -110,500 | -100.0% | -0.50% | – |
QTRX | Exit | QUANTERIX CORP | $0 | – | -132,200 | -100.0% | -0.61% | – |
AQST | Exit | AQUESTIVE THERAPEUTICS INC | $0 | – | -738,500 | -100.0% | -0.84% | – |
ACHN | Exit | ACHILLION PHARMACEUTICALS INC | $0 | – | -760,000 | -100.0% | -0.90% | – |
RARX | Exit | RA PHARMACEUTICALS INC | $0 | – | -141,800 | -100.0% | -1.31% | – |
BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -100,000 | -100.0% | -1.57% | – |
BHVN | Exit | BIOHAVEN PHARMACEUTICAL HLDG | $0 | – | -165,000 | -100.0% | -1.76% | – |
PTCT | Exit | PTC THERAPEUTICS INC | $0 | – | -191,000 | -100.0% | -1.80% | – |
AXGN | Exit | AXOGEN INC | $0 | – | -700,000 | -100.0% | -2.46% | – |
ITCI | Exit | INTRA CELLULAR THERAPIES INC | $0 | – | -406,600 | -100.0% | -2.74% | – |
BOLD | Exit | AUDENTES THERAPEUTICS INC | $0 | – | -292,000 | -100.0% | -3.43% | – |
TPTX | Exit | TURNING POINT THERAPEUTICS INC | $0 | – | -340,500 | -100.0% | -4.16% | – |
EPZM | Exit | EPIZYME INC | $0 | – | -1,384,200 | -100.0% | -6.68% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
CODEXIS INC | 39 | Q3 2023 | 10.9% |
CHIMERIX INC | 31 | Q3 2022 | 16.4% |
XOMA CORP DEL | 27 | Q3 2023 | 3.6% |
FIBROGEN INC | 26 | Q1 2021 | 6.8% |
BIOLINERX LTD (Does not reflect a reverse stock split effectuated after June 30, 2019) | 26 | Q1 2020 | 2.4% |
OCULAR THERAPEUTIX INC | 24 | Q3 2023 | 17.6% |
AXOGEN INC | 20 | Q4 2019 | 18.7% |
ETON PHARMACEUTICALS INC | 20 | Q3 2023 | 5.6% |
AMARIN CORP PLC | 20 | Q4 2020 | 6.6% |
IMPRIMIS PHARMACEUTICALS INC | 19 | Q1 2020 | 5.9% |
View Opaleye Management Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
CHIMERIX INCSold out | February 13, 2023 | 0 | 0.0% |
Larimar Therapeutics, Inc. | January 23, 2023 | 1,560,000 | 3.6% |
TELA Bio, Inc. | June 10, 2022 | 1,557,500 | 10.7% |
Gemini Therapeutics, Inc. /DESold out | February 01, 2022 | 0 | 0.0% |
Adamas Pharmaceuticals IncSold out | January 26, 2022 | 0 | 0.0% |
AVENUE THERAPEUTICS, INC. | February 12, 2021 | 9 | 11.0% |
Cardiff Oncology, Inc. | February 12, 2021 | 9 | 11.0% |
EDAP TMS SA | February 12, 2021 | 9 | 11.0% |
Fortress Biotech, Inc. | February 12, 2021 | 9 | 11.0% |
Gemini Therapeutics, Inc. /DE | February 12, 2021 | 9 | 11.0% |
View Opaleye Management Inc.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
4 | 2024-05-10 |
4 | 2024-04-25 |
4 | 2024-04-24 |
4 | 2024-04-19 |
SC 13G/A | 2024-04-09 |
SC 13G | 2024-04-08 |
4 | 2024-03-28 |
4 | 2024-03-22 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View Opaleye Management Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.